Sherbrooke Park Advisers’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,693
Closed -$325K 588
2025
Q1
$325K Sell
3,693
-1,662
-31% -$157K 0.15% 269
2024
Q4
$489K Buy
5,355
+3,013
+129% +$309K 0.16% 223
2024
Q3
$262K Buy
+2,342
New +$234K 0.06% 635
2024
Q2
Sell
-2,547
Closed -$255K 987
2024
Q1
$255K Sell
2,547
-6,605
-72% -$581K 0.05% 631
2023
Q4
$822K Sell
9,152
-6,673
-42% -$532K 0.39% 78
2023
Q3
$1.21M Buy
15,825
+8,525
+117% +$707K 0.39% 63
2023
Q2
$611K Sell
7,300
-1,100
-13% -$89.4K 0.32% 125
2023
Q1
$708K Buy
8,400
+900
+12% +$77.3K 1.07% 15
2022
Q4
$611K Buy
+7,500
New +$604K 0.45% 83

Other funds holding EMN

Sherbrooke Park Advisers's EMN Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 3,693 shares — an estimated $325K sold.

Sherbrooke Park Advisers first reported a position in EMN in Q4 2022 and held it in 9 quarters. The position peaked at $1.21M in Q3 2023. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 3,693 Eastman Chemical shares in Q2 2025, an estimated $325K.
  • Sherbrooke Park Advisers first reported a position in Eastman Chemical in Q4 2022 and held it in 9 quarters.
  • Sherbrooke Park Advisers's Eastman Chemical position peaked at $1.21M in Q3 2023.
  • 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.